| abstract |
The technology relates in part to peptide compositions, including peptide vaccine compositions, for the treatment of a disease or condition caused by a pathogen, such as a virus, including coronaviruses such as SARS-CoV-2. The technology also relates in part to methods of selecting peptides for preparing the compositions, and to methods of treatment, including prophylactic treatment, using the compositions. |